Cargando…

Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses

The majority of oesophageal adenocarcinoma (OAC) patients do not respond to multimodal treatment regimens and face dismal survival rates. Natural killer (NK) cells are crucial anti-tumour immune cells, and this study investigated the susceptibility of treatment-resistant OAC cells to these potent tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mylod, Eimear, McKenna, Ellen, Davern, Maria, Barr, Martin P., Donlon, Noel E., Bibby, Becky A. S., Bhardwaj, Anshul, Reynolds, John V., Lysaght, Joanne, Maher, Stephen G., Conroy, Melissa J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224847/ https://www.ncbi.nlm.nih.gov/pubmed/35364779 http://dx.doi.org/10.1007/s10238-022-00811-6

Ejemplares similares

The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism
por: Mylod, Eimear, et al.
Publicado: (2021)

Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells
por: Davern, Maria, et al.
Publicado: (2023)

Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma
por: Donlon, Noel E, et al.
Publicado: (2022)

Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells
por: Davern, Maria, et al.
Publicado: (2021)

Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses
por: Moran, Jennifer, et al.
Publicado: (2023)

Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer
por: Donlon, Noel E, et al.
Publicado: (2023)

The future of combination immunotherapy in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)

PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
por: Davern, Maria, et al.
Publicado: (2022)

The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling
por: Donlon, Noel E., et al.
Publicado: (2021)

The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition
por: Donlon, Noel E., et al.
Publicado: (2022)

Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play
por: Donlon, Noel E., et al.
Publicado: (2021)

PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours
por: Davern, Maria, et al.
Publicado: (2022)

Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells
por: Buckley, Amy M., et al.
Publicado: (2019)

MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma
por: Bibby, Becky A. S., et al.
Publicado: (2015)

Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma
por: O’Connell, Fiona, et al.
Publicado: (2023)

FLOT and CROSS chemotherapy regimens alter the frequency of CD27(+) and CD69(+) T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy
por: Davern, Maria, et al.
Publicado: (2022)

Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma
por: Bibby, Becky A. S., et al.
Publicado: (2019)

Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib
por: Buckley, Amy M., et al.
Publicado: (2020)

PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)

Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy
por: Davern, Maria, et al.
Publicado: (2022)

Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers
por: King, Ross, et al.
Publicado: (2021)

Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma
por: Mongan, Ann Marie, et al.
Publicado: (2019)

Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines
por: Donlon, Noel E., et al.
Publicado: (2020)

Resection of oesophageal and oesophagogastric junction cancer liver metastases — a summary of current evidence
por: Weiss, Andreas R. R., et al.
Publicado: (2021)

Case of oesophageal gastrointestinal stromal tumour
por: Łochowska, Barbara, et al.
Publicado: (2017)

Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8(+) T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients
por: Conroy, Melissa J., et al.
Publicado: (2018)

Curcumin induces apoptosis-independent death in oesophageal cancer cells
por: O'Sullivan-Coyne, G, et al.
Publicado: (2009)

Alterations in the Ca(2+) toolkit in oesophageal adenocarcinoma
por: Cutliffe, Alana L., et al.
Publicado: (2021)

Rare oesophageal tumours: experience of one centre
por: Zielinski, J., et al.
Publicado: (2012)

Hydropneumopericardium: A Rare Complication of an Oesophageal Tumour
por: Rodrigues Morais, Joana, et al.
Publicado: (2022)

Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
por: Russell, Éilis, et al.
Publicado: (2022)

Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment
por: Mockler, Mary B., et al.
Publicado: (2014)

Oesophageal squamous cell carcinoma mimicking submucosal tumour
por: Wang, Wen, et al.
Publicado: (2021)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
por: Li, Sile, et al.
Publicado: (2021)

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.
por: Kok, T. C., et al.
Publicado: (1996)

Histological Typing of Gastric and Oesophageal Tumours (International Histological Classification of Tumours No. 18)
por: Dodge, O. G.
Publicado: (1979)

Measurement of the acute metabolic response to hypoxia in rat tumours in vivo using magnetic resonance spectroscopy and hyperpolarised pyruvate
por: Bluff, Joanne E., et al.
Publicado: (2015)

Successful maintenance of process and outcomes for oesophageal cancer surgery in Ireland during the first wave of the COVID-19 pandemic
por: Bolger, Jarlath C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jj5fsn86qmg2qgkhtb2oeh09c0